Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Oncotarget|September 23, 2015
The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growthMichal Hameiri-Grossman, Adi Porat-Klein, Isaac Yaniv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2026
Epigenetic Liquid Biopsy Enables Universal Mutation-Agnostic Molecular Surveillance for High-Risk NeuroblastomaNurit Gal-Mark, Assaf Grunwald, Valid Gahramanov, et al.
Cancers|September 13, 2025
Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect ComparisonHolger N Lode, Przemysław Holko, Aleksandra Wieczorek, et al.
Pediatric Blood & Cancer|April 3, 2023
Optimising urinary catecholamine metabolite diagnostics for neuroblastomaYvette A H Matser, Iedan R N Verly, Maria van der Ham, et al.
Journal of Pain and Symptom Management|September 28, 2023
Challenges in Implementing Guideline on Integrative Oncology and Pain: The Israeli PerspectiveEran Ben-Arye, Jun Mao, Eduardo Bruera, et al.
Pediatric Blood & Cancer|July 18, 2018
Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN studyDaniel A Morgenstern, Ulrike Pötschger, Lucas Moreno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2025
Fcγ Receptor Polymorphism in Patients with Relapsed/Refractory High-Risk Neuroblastoma Correlates with Outcomes in the SIOPEN Dinutuximab Beta Long-Term Infusion TrialHolger N Lode, Nikolai Siebert, Dominique Valteau-Couanet, et al.
Frontiers in Pediatrics|October 27, 2022
Presenting features of neuroblastoma with spinal canal invasion. A prospective study of the International Society of Pediatric Oncology Europe - Neuroblastoma (SIOPEN)Stefania Sorrentino, Shifra Ash, Riccardo Haupt, et al.
Frontiers in Oncology|February 9, 2026
Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisonsHolger N Lode, Przemysław Holko, Aleksandra Wieczorek, et al.
Pediatric Blood & Cancer|May 29, 2024
Anaplastic sarcoma of the kidney (DICER1-sarcoma of the kidney): A report from the International Pleuropulmonary Blastoma/DICER1 RegistryPeter J Schoettler, Caroline C Smith, Miki Nishitani, et al.
Pageof 8